Veterinary Medicines

AUREOZÁSYP 20 mg/g dermálny zásyp

Authorised
  • CHLORTETRACYCLINE HYDROCHLORIDE
  • Benzocaine
Download as PDF

Product identification

Medicine name:
AUREOZÁSYP 20 mg/g dermálny zásyp
Active substance:
  • CHLORTETRACYCLINE HYDROCHLORIDE
  • Benzocaine
Target species:
  • Cattle
  • Sheep
  • Pig
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • CHLORTETRACYCLINE HYDROCHLORIDE
    20.00
    milligram(s)
    /
    1.00
    gram(s)
  • Benzocaine
    10.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Cutaneous powder
Withdrawal period by route of administration:
  • Cutaneous use
    • Cattle
      • All relevant tissues
        no withdrawal period
    • Sheep
      • All relevant tissues
        no withdrawal period
    • Pig
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD06AA52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Cymedica spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cymedica spol. s r.o.
Responsible authority:
  • USKVBL
Authorisation number:
  • 96/0330/96-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 23/11/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."